News | July 23, 2024
Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr
Solara Active Pharma Sciences has reported total income of Rs. 364.05 crores during the period ended June 30, 2024
Solara Active Pharma Sciences has reported total income of Rs. 364.05 crores during the period ended June 30, 2024
The integrated company delivers a broad portfolio of over 30,000 lab products across microscopy, histology, and other research areas
RPG Life Sciences has reported total income of Rs. 167.79 crores during the period ended June 30, 2024
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
Vimta Labs has reported total income of Rs. 82.44 crores during the period ended June 30, 2024
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Subscribe To Our Newsletter & Stay Updated
